CDKN1A and cancer: In addition, ACTL6A stabilizes the YAP1/TAZ pro-cancer transcriptional regulators, which are part of the Hippo signaling cascade [18, 19], and reduces expression of the p21Cip1 tumor suppressor [20–23].